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Abstract: Given the exponential availability of data in health centers and the massive sensorization that
is expected, there is an increasing need to manage and analyze these data in an effective way. For this
purpose, data mining (DM) and machine learning (ML) techniques would be helpful. However, due to
the specific characteristics of the field of healthcare, a suitable DM and ML methodology adapted
to these particularities is required. The applied methodology must structure the different stages
needed for data-driven healthcare, from the acquisition of raw data to decision-making by clinicians,
considering the specific requirements of this field. In this paper, we focus on a case study of cervical
assessment, where the goal is to predict the potential presence of cervical pain in patients affected with
whiplash diseases, which is important for example in insurance-related investigations. By analyzing
in detail this case study in a real scenario, we show how taking care of those particularities enables the
generation of reliable predictive models in the field of healthcare. Using a database of 302 samples,
we have generated several predictive models, including logistic regression, support vector machines,
k-nearest neighbors, gradient boosting, decision trees, random forest, and neural network algorithms.
The results show that it is possible to reliably predict the presence of cervical pain (accuracy, precision,
and recall above 90%). We expect that the procedure proposed to apply ML techniques in the field of
healthcare will help technologists, researchers, and clinicians to create more objective systems that
provide support to objectify the diagnosis, improve test treatment efficacy, and save resources.
Keywords: data mining; data anonymization; health; cervical injury; neck pain; inertial sensors
1. Introduction
In the field of healthcare, the exponential increase in the data that health centers must produce and
manage is significant. The need has arisen to develop procedures that make this process easier and that
take advantage of all the data generated [1], detecting unknown and valuable information in health
data [2]. Thus, the volume of data generated is such that its processing and analysis by traditional
methods is too complex and overwhelming [3]. To tackle this challenge, data mining (DM) can play a
key role, as it allows the discovery of patterns and trends in large amounts of complex data and the
extraction of hidden information to help in making decisions that can improve the quality of the care
processes [4–7]. It is closely linked with the scientific discipline in the field of artificial intelligence
called machine learning (ML), which “employs a variety of statistical, probabilistic and optimization
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techniques that allow computers to learn from past examples and to detect hard-to-discern patterns
from large, noisy or complex data sets” [8].
Consequently, ML is generating growing interest in the field of healthcare (e.g., see [9,10])
for relevant special issues related to this topic), mainly derived from its possible applications, such as
assessing the effectiveness of treatments, detecting fraud and abuse in health insurance, managing
healthcare, making lower-cost medical solutions available to the patients, detecting symptoms and
diseases [11], discovering treatment patterns from electronic medical records [12], detecting groups
of incidents [13], and identifying medical treatment methods [2,3]. Likewise, ML also presents
health benefits: (1) a potential reduction in the time and effort required for diagnosis and treatment,
(2) the ability to examine multiple areas simultaneously, (3) a decreased potential for human error,
and (4) data that are accessible anytime and anywhere [14]. Besides, DM and ML are key in the path
towards personalized medicine, where the goal is to customize treatments to the specifics of each
individual [15–18].
However, to take full advantage of the benefits offered by ML in the field of healthcare,
several considerations are necessary. Among others, the following aspects can be highlighted:
• The data have to be structured and organized in order to properly process and transform them
into suitable variables, which is essential in the development of any pattern recognition software
and a highly problem-dependent task [19,20].
• Moreover, the secure treatment and management of data acquires special relevance in the field
of healthcare, where the privacy of the patient must be ensured. The management of sensitive
data contrasts with other fields of application of ML (fraud detection, stock prediction, etc.),
where anonymization treatments may be sometimes not necessary or critical. Therefore, a specific
treatment involving the anonymization and categorization of the data must be performed in order
to ensure the privacy of the patients [21]. Due to privacy policies, on certain occasions if a suitable
anonymization of the data is not performed and/or the required authorizations to access some
data are not obtained, the needed health studies cannot be carried out. Therefore, data availability
should also be considered as a key factor [21].
• Another difference with other ML applications is the existence of different costs of failures; in the
health area, the cost of a false negative (e.g., failing to detect that a patient has a specific disease) is
usually much higher than the cost of a false positive (e.g., if a person is initially considered to
have a disease that he/she does not really have, additional tests will be performed to rule this out,
which may be costly but usually less harmful than failing to diagnose an existing disease).
• It should also be considered that ML hardly ever follows a linear sequence ending at the first
attempt; instead, it is rather an iterative feedback process where the stages interact with each
other. Furthermore, in the field of healthcare, where the flow of data is continuous and constant,
it is reasonable to assume that the model can be designed to be a “learning” model that must be
continuously updated to improve its predictions over time. Therefore, the different stages needed
to generate a reliable predictive model should be properly structured, from the acquisition of raw
data to decision-making, which is essential to achieve the effectiveness of the model [22].
All this motivates the need to define the particularities of the application of ML techniques in the
field of healthcare, where different stages in the ML workflow must be correctly defined and structured.
The proper application of ML techniques would be beneficial for the clinicians, researchers, developers,
and designers involved in the field of health, where the management of information acquires a
transcendental role. It would favor the design of new products and services for improving healthcare
access [23], creating truly accessible technological solutions [24], and enhance the relationship between
health systems and people by providing adequate services at the right time [23].
Based on the above, the aims of this study are the following: (1) to show and develop the
particularities of applying ML techniques in the field of healthcare, detailing all the stages that comprise
this process, from the acquisition of raw data to the decision-making derived from the predictive model
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generated; and (2) to demonstrate and show its practical application in a real use case. Specifically,
the ML process is applied in a cervical pain assessment study with patients affected by whiplash
pathologies derived from traffic accidents or other causes. This case study shows the proposed
methodology in action to solve a specific relevant problem. Moreover, the applied procedure can be
used as an ML application guide for other similar studies in the field of healthcare. We believe that the
combination of the use case study and the machine learning methodology is a relevant contribution of
this paper. We do not remain in the theoretical/methodological part only or limit our work to apply
different machine learning algorithms and compare the results, as many other works do; instead,
we describe the whole machine learning process, highlighting the aspects that are more relevant for our
use case but at the same time providing a general framework that could be used in other health-related
projects. In this way, we think that the paper could be relevant both as a specific case study and also as
a reference and guideline for other similar projects.
The structure of the rest of this paper is as follows. In Section 2, we present the use case scenario
studied and the clinical methods used for data collection. In Section 3, we describe the proposed
procedure to develop predictive models for healthcare, illustrating each step with our work on the
case study. In Section 4, we present an overall discussion of the proposal and the lessons learnt.
Finally, in Section 5, we summarize our conclusions, the limitations of the study, and some ideas for
future work.
2. Use Case Scenario and Clinical Methods
To illustrate the particularities of using ML techniques in the health area, a case study related to
the detection of cervical pain is considered. The goal is to try to estimate automatically the presence
of cervical pain, which can help to objectify a diagnosis and to clarify issues in case of insurance
litigation. The selection of cervical pathology as a case study in this work is motivated by the fact
that musculoskeletal disorders of the cervical spine have a high incidence and prevalence and are
considered a public health problem, especially in developed countries [25,26]. Likewise, cervical
injuries (usually due to whiplash after a traffic accident) are difficult to diagnose [26] because traumatic
cervical spine injuries and their associated symptoms are diverse [25].
A real dataset was collected by evaluating the movement of the cervical spine in 151 patients
(60 asymptomatic subjects, 42 with cervical pain resulting from a traffic accident, and 49 with neck
discomfort due to other causes). Cervical movement assessment tests were performed by using an
MH-sensor motion capture system [27,28] (see Figure 1). The participants performed a sequence
of functional cervical Range of Motion (ROM) tests of the following movements: flexion-extension,
rotation, and lateralization (Figure 2). The patients were collaborating subjects in order to avoid
disturbances produced by non-collaborating subjects immersed in a judicial process with an insurance
company [29]. The medical test was performed twice with each patient, giving a total of 302 samples.
Moreover, all the participants, who were either asymptomatic or had cervical pain, were also
assessed with a clinical examination to verify that they met the inclusion criteria:
• age between 18 and 65 years;
• not immersed in a judicial process;
• no presence of surgery and/or cervical fracture.
The medical inspection, assessment by scales/clinical tests, and development of the clinical profile
of the patients were conducted by clinicians. All the participants received information about the
experiment and signed a consent agreement prior to the testing. The study received a favorable verdict
from the Bioethics Committee of Aragón in Spain (CEICA) on 25 July 2017.
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3. Proposed Procedure to Develop Predictive Models in Healthcare
A predictive model to support decision-making in the field of healthcare should be able to make
predictions relative to relevant target clinical variables. The final goal is to deploy a system that
can help in clinical decision-making (e.g., objectifying diagnoses, testing the efficacy of treatments,
saving resources, providing suitable and customized treatments, etc.). The proposed procedure for
continuous use in the field of healthcare is summarized and outlined in Figure 3.
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In order to adapt and particularize the usual process of applying ML techniques in the healthcare
field and develop the project management procedure, some outstanding studies such as [20,30], as well
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as the most widespread DM processes, such as knowledge discovery in databases (KDD) [31,32];
sample, explore, modify, model, and assess (SEMMA) [14,32]; and the cross-industry standard process
for DM (CRISP-DM) [32–35], have been considered as a reference. Likewise, the project management
procedure scheme proposed (shown in Figure 4) has been inspired by different outlines of clinical
applications proposed by different authors [4,19,36–38] and adapted and extended according to our own
experience and the work performed with clinicians in our case study and other related collaborations,
such as the project “Mobile units for functional assessment of the musculoskeletal system” (CEICA
reference of the project: OTRI-2019/0108) in collaboration with the hospital MAZ (Mutua de Accidentes
de Zaragoza, Zaragoza, Spain), whose goal was to predict the degree of collaboration of patients in
insurance litigation.
From the related proposals mentioned above, the CRISP-DM process has been our main inspiration
to develop the project management procedure proposed in this paper. This is to be expected because
CRISP-DM sets a general common framework that can be adapted to different scenarios. Thus,
there are similarities between the six stages in CRISP-DM and our seven-stage proposal. For example,
the CRISP-DM stage 6 “deployment” is closely related to our last stage, which is “operating profit
and clinical use”. As another example, stage 6 of CRISP-DM establishes that the creation of the model
is not the end of the project and, similarly, in healthcare the knowledge provided to the clinician
through the application of the predictive model is not the end of the process, since the system is
continuously acquiring new data to improve the clinical performance. As the main difference between
both procedures, we put more emphasis on data management aspects, since this is a key point in
healthcare, and consider the whole process from the perspective of its application in a healthcare
scenario. While only one stage for data management is considered in the CRISP-DM process (stage
3, “data preparation”), data management is the focus of three stages in our proposal (stage 2 “data
acquisition and understanding”, stage 3 “data transformation”, and stage 4 “data selection”).
The works mentioned in this section have inspired our proposal, which extends existing models
by including a thorough analysis of all the data management challenges, as well as an illustration of
each step through a real practical case study. Although the particularities of applying ML techniques
in healthcare are exemplified in a specific case study, the procedure presented is flexible enough to
adapt to any healthcare case.
3.1. Stage 1: Clinical Target Definition
In the first stage, the aim of the system is established—that is, the variables with clinical significance
that the system should be able to predict are identified. Likewise, the final performance of the model
and the statistical measures that will define its performance must also be defined. Measures such as
the accuracy, precision, or recall are usual metrics used to assess the performance of a classification
model, and metrics such as the Mean Absolute Error (MAE) or Root Mean Squared Error (RMSE),
to cite two examples can be used to evaluate the accuracy of a numeric prediction.
In predictive classification in a healthcare domain, it is usual that some metric must be highlighted
in such a way that the model must always be generated with the aim to minimize it. This metric
is usually the number of false negatives (affecting the recall metric). The reason for this is that,
in healthcare, false negatives and false positives have no similar costs, which has always been an issue
that clinicians have had to deal with [39]. Moreover, the clinical need must be identified (e.g., to classify
a certain type of pathology, to predict a pattern or behavior, etc.). In addition, the sample size and
viability of the project must be assessed prior to its realization [34].
Application to our Case Study
In our case study, the aim of the prediction model is to predict the presence of cervical pain (the
target variable) in patients who have suffered whiplash or suffer from chronic cervical pathology.
In our collected dataset, the cervical pain is a binary variable (the presence or absence of pain) which
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has been reported by the collaborating subjects, who were real patients undergoing an assessment
process in a hospital.
Predicting the presence of cervical pain is of interest especially in the forensic field, as the incidence
and prognosis of whiplash injury from motor vehicles is relevant to insurance litigations for pain and
suffering [29]. The aim is to determine the presence or absence of pain with enough confidence to be
able to aid clinicians to detect possible magnifications of the injury by the affected individuals and thus
establish an unbiased compensation for the cervical pain [40]. It can help to identify and objectify pain
in patients with a high degree of anxiety and in hypochondriac patients.
Without a loss of generality, the following target metrics have been determined for the purpose of
this study, whose required threshold values have been stablished according to the criteria of clinical
experts (for this particular case study, they considered that achieving this quality criteria would be
enough for the system to be used as a decision-support system in production):
• Accuracy: greater than 85%.
• Precision: greater than 85%.
• Recall: greater than 90%.
The sample size is 302; although this is not a very large dataset, it contains a lot of variables
with relevant information to characterize the presence of cervical pain during insurance litigation,
which allows predicting the target variable, thus considering the project viable.
3.2. Stage 2: Data Acquisition and Understanding
The second stage implies identifying different sources that will allow access to the data necessary
to feed the model, both in the initial phase of model design (initial training), as well as regarding
a future continuous feedback when it reaches the operational stage of application in the field of
healthcare. Likewise, the typology of these data will also be identified and selected. The level of
accuracy that these sources of information can provide and the frequency of data collection (which may
be determined by aspects such as the cost of the equipment needed, the availability of collaborating
patients, etc.) will be considered in the choice [34].
In the field of healthcare, due to the diverse origins of data, their typology, their consistency,
and even their veracity, the process of categorization of the data acquires special relevance for their
correct structuring, understanding, and subsequent treatment.
When there are patient’s personal data that make the identification of the patient possible,
proper anonymization techniques must be applied. Apart from direct identification data (such as the
name and last name of the patient, his/her history number, or his/her card ID), other data such as the
age, nationality, height, weight, diagnosis, etc., can be used for indirect patient identification. In stage
3 “Data transformation” (see Section 3.3), certain techniques are presented to safeguard the privacy of
patients and avoid the loss of useful information for the generation of the model, but these sensitive
variables must be identified in this second phase.
Although there are classifications of information and data in the healthcare environment [30],
alternative complementary classifications are proposed in this paper for a better understanding and
structuring of the data. This has been motivated by the needs of medical staff, as well as by specialists of
the medical legal/forensic field collaborating with us in our case study: a greater variety of classifications
is of interest in order to include the perspectives of all the parties involved.
Clinical Data and Patient Data
Firstly, two types of data related to patients can be identified when we distinguish between clinical
data and other data related to the patient:
• Patient characterization data. They are generally static data (although there may be small
fluctuations in certain data values over large time intervals, such as in the case of the weight of
the patient). They can be grouped in the following categories:
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• Identification data: name, age, gender, educational level, nationality, etc.
• Temporary data: dates of control or highlighted clinical evolution, visits to the hospital,
start and end of treatments, etc.
• Anthropometric data: measurements of the size and proportions of the human body, such as
the height, weight, percentage of fat and muscle, foot length, abdominal perimeter, etc.,
that usually require instrumentation to be obtained (scale, tape measure, etc.).
• Daily life activities (DLA) data: data usually reported by the patient related to the habits and
activities that he/she usually performs on a daily basis. In some cases, some of these data can
be measured using wearables sensors or other devices deployed in smart homes.
• Clinical data: data of a medical nature that may require instrumentation and medical tests for
their acquisition.
Data According to the Degree of Objectivity
Another possible classification is to categorize the data according to the degree of objectivity:
• Measures: objective data that do not require assessment by a clinician. These data are not affected
by the reproducibility factor. Examples are test or clinical scales, test results, or data collected
by medical instrumentation. Data recorded by sensor devices provide objective data on some
measurable dimensions of the patient and can be of different types: motion capture (MoCap)
sensors, surface electromyography (EMG), stabilometric platforms, dynamometers, etc.
• Assessed data: information that depends on the assessment of the clinician, such as diagnoses
and treatments.
• Reported data: subjective information provided by the patient regarding his/her condition
(perceived symptoms).
Data According to Clinical Considerations
We also present a classification that groups the collected data according to clinical considerations:
• Clinical profile: data about symptoms and clinical signs of the patient that can lead to a diagnosis
by the clinician. We refer to symptoms when they are of subjective nature, reported by the patient,
and to signs if they are objective and obtained by the clinician about the pathology. In addition,
the signs can be qualitative (binary) or (discrete or continuous) quantitative (e.g., the temperature
of a thermometer, image tests, other measurements, etc.).
• Treatment data: data about the treatment that the clinician has prescribed, such as the type of
treatment, number of rehabilitation sessions, drugs received, surgery, etc.
• Clinical scales, tests, or surveys: data resulting from scales or validated and protocolized tests
whose objective is to obtain objective information about the patient (e.g., the timed up and go test,
the Unterberger test, psychological tests, etc.).
• Medical history: data concerning the patient’s clinical history, ordered chronologically
(e.g., first hospital visit, imaging test for diagnosis, treatment administration after diagnosis, etc.).
Data According to their Data Types
Finally, the different data variables can be grouped according to their types, independently of the
specifics of the health area. For example, we could consider:
• Qualitative variables: also called categorical variables, they are variables that are not numerical.
They describe data that fit into categories (e.g., educational level, the level of development of a
disease, the level of invasiveness of a treatment, etc.).
• Quantitative variables: also called measurement or numerical variables, they represent quantities
of different nature. They can be divided into discrete variables that can only take a finite
number of values (e.g., the number of rehabilitation sessions, score on a clinical scale, age, etc.),
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and continuous variables, which can take values in an infinite/continuous range of possible values
(e.g., the temperature of a thermometer, weight, Body Mass Index (BMI), etc.).
• Textual data: data that are directly collected in text format, such as handwritten annotations in
medical histories.
In this stage, data profiling [41] and cleaning [42] must be applied to detect potential problems
and, if possible, fix them. By categorizing the data, using one of the proposed classifications (or another
one that could be useful for a specific use case) independently, or several of them at the same time,
the process of the understanding and assimilation of the data available and their scope is facilitated.
This step must be carried out to obtain a preliminary database, containing the data collected, that will be
called the initial database. For this task, having the support of both a clinical expert and a technologist
is recommended. In some cases, when the amount of data to handle is large or coming from different
data sources, a data warehouse can be created to integrate all the information and allow the easy and
efficient analysis of the data stored [43,44].
During data collection for classification tasks, it is also important to collect enough
instances/samples to represent in an appropriate way the different classes that must be predicted.
In case there is imbalance regarding the number of samples in the different target classes, this should
be identified as part of the data profiling, and some strategies could be applied to deal with this
issue [45,46] (e.g., to try to prevent the majority class from dominating the predictions in a harmful way).
Application to Our Case Study
In this case study, the initial database was prepared according to the final goal, which was
predicting the presence/absence of cervical pain. The categorization of the data was jointly agreed
by physicians and technologists, considering the application of this research in the legal field and the
degree of objectivity of the data. According to the four classifications presented, the data from our case
study could be classified as shown in Table 1, following the exposed criteria:
Table 1. Possible classifications of the case study data.
1. Clinical Data and Patient
Data
2. Data According to the
Degree of Objectivity
3. Data According to the
Clinical Considerations
4. Data According to
Their Data Types
Patient characterization data:
- Identification: name, age,
gender, educational level, etc.
- Temporary: accident date,
visits to the hospital, date of
the range of motion (ROM)
test, etc.
- Anthropometric: weight,
height, body mas index, foot
length, etc.
- Daily life activities:
physical activity intensity,
workplace, etc.
Measures: all the data
















Clinical data: feeling of
instability, surgery, all the








- Discrete: WDQ, age, etc.
- Continuous: all the data





Clinical scales or tests:
WDQ. Textual data: n/a.
Medical history: accident
date, visits to the
hospital, etc.
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The classifications shown in Table 1 illustrate different useful perspectives of the data collected in
the case study. Specifically, and considering the final goal of objectively predicting the presence of
cervical pain, the classification that best suited the point of view of the health professionals participating
in our case study was the following (a combination of the first two classification approaches described):
• Patient characterization data: the data measured and reported, such as the identification
information (e.g., ID, age, gender, etc.), anthropometrics (e.g., height, weight, BMI, etc.), and data
relative to the activities of daily life (e.g., weekly physical activity and its intensity, workplace, etc.).
• Assessed and reported data: such as the characterization of a cervical accident (e.g., the time since the
accident, type of impact of the traffic accident, position of the head, type of effect, etc.), qualitative
signs (e.g., column alterations and contractures), clinical scales (e.g., whiplash scale—WDQ),
and symptoms (e.g., instability, limitation of mobility, etc.).
• Measured data: such as data from a cervical assessment test with MoCap or from each movement
studied, for example the angles reached and the speeds of the movements (e.g., maximum values,
minimum values, average values, etc.).
For the purposes of medical legal/forensic assessments, a classification according to the degree of
objectivity of the clinical data (assessed and reported) is of interest. Thanks to the understanding of an
expert technologist in insurance litigation, it has been possible to identify objective information in the
case study, such as the presence of a contracture, column alterations, the WDQ, the characterization of
the traffic accident (in case such an event had occurred), etc.
The initial database is presented as Supplementary Material File S1, which collects the dataset
that has been considered for the development of the model.
3.3. Stage 3: Data Transformation
Once the data to be considered in the initial database have been selected, certain transformations
of the data must be performed in order to handle empty values, perform data transformations to
define the required variables and adapt them to the required format, and ensure the anonymization of
the data.
The information obtained from the different sources can correspond to variables already defined
and structured or to raw data, and it can be presented as numerical, text, curves, images, etc. [47].
Transforming raw data into the format required for the application of specific ML algorithms is a
common pre-processing step to be performed, and it could also be useful because the volume of data to be
handled could be reduced, and its predictive power could be significantly increased, making it possible
to have a significantly lower volume of data to achieve a reliable and stable predictive model [5,19].
To be exploited by traditional DM and ML algorithms, textual data can be transformed into structured
variables and different text mining techniques can be applied [48,49]. Besides, depending on the
purpose, unsupervised learning approaches can be applied on the texts—for example, for dimensionality
reduction (e.g., using the Self-Organizing Map (SOM) method [50]), for clustering documents according
to their similarity, or for discovering topics in documents (e.g., probabilistic topic modeling by using
Latent Dirichlet allocation) [51].
This stage of transformation of raw data is known as feature engineering and is performed prior
to modelling [52]. In some cases, several data mining techniques can be applied to extract features from
raw data. For example, Principal Component Analysis (PCA), like the SOM method mentioned above,
is a dimensionality reduction method that is often used to reduce the dimensionality of large data sets;
it can be used to tackle the problem of high dimensionality that appears in some projects when the
number of variables is excessively high compared to the total number of samples (see Section 3.5) [39].
In the field of healthcare, the following types of transformations can be highlighted:
• Texts that become “positive or negative opinions”, concepts, dates, values, etc., through the
application of text mining techniques [53,54].
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• Images of medical tests that are converted into binary variables related to a pathology or other
binary representations.
• Curves or other graphical representations from which information can be extracted as statistical
variables, such as the mean, standard deviation, skewness, quartiles, etc.
• Different imputation techniques [18,55–57] that can be applied in order to fill empty values,
either by means of interpolation or by using other procedures. Alternatively, some records may
need to be discarded (e.g., if several key data values are missing).
• The potential addition or creation of variables based on the knowledge of clinical experts and
technologists, either as a combination of existing variables or based on experience acquired in
similar studies [30].
• Data anonymization, applied in order to preserve the privacy of patients [58]. The trade-off
between privacy and information loss should be considered. A detailed analysis of data
anonymization techniques for health data is out of the scope of this work but, for illustration
purposes, some examples of transformations that can be applied to guarantee the privacy of
sensitive information are:
• Transformation of continuous variables (e.g., age, size, weight, income, etc.) into ordinal
variables by defining suitable ranges. Normalization (e.g., min-max normalization) or
standardization (z-score scaling) techniques could also be applied to transform the quantitative
variables into variables in the range from 0 to 1.
• Transformation of qualitative variables (e.g., diagnosis, treatment, education level, etc.),
that could be classified, according to a scale, into ordinal variables (e.g., severity of
diagnosis, treatment risks, range of studies (“high school”, ”BS”, ”MS”, “PhD”), etc.).
In this way, these variables cannot be associated with a specific patient, thus preserving the
patient’s privacy.
• Transformation of qualitative variables (e.g., nationality, physical description, address, etc.),
that could not be classified according to a scale into groups (e.g., by continents or country
grouping, by groups according to a general description, by postal code, etc.) so that these
variables cannot be associated with a specific patient.
• The previous anonymization techniques are examples of the generalization of attribute values.
Other possible techniques and privacy-preservation methodologies include adding noise [59],
k-anonymity [60], differential privacy [61], etc.
Another important aspect to mention here is the need for the normalization of quantitative
attributes; if we have quantitative variables with very different scales, the variables that can take larger
values could end up dominating others when learning a predictive model. This is unsuitable because
it mistakenly attributes more importance to those variables just because their usual values are higher
than the values of other variables.
After applying the specified transformations, the initial database is transformed to an encoded
(modified) database, which includes all the available information in the format of multiple variables.
Application to Our Case Study
In the case of the cervical pain assessment study, this process consisted of transforming the data
from the MoCap sensors into variables (i.e., mean, deviation, maximum, minimum, etc., of the range
of the movement) and transforming the clinical and characterization data of the patients into variables
considering sensitive variables and their anonymization. Some ranges of variables were associated
with a numeric coding to improve the anonymization process and the generation of the predictive
model. The process was carried out jointly by a clinical expert and a technologist. As in our case study
we have transformed all the quantitative variables into discrete variables, no additional normalization
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was needed. The following are examples of the transformations performed (the numeric coding used
is indicated in brackets):
• Age transformation in a three-tier classification: under 30 (0), between 30 and 55 (1), and over 55 (2).
• Transformation of the level of weekly exercise into a classification of three levels as a function of
the time required and the intensity of the exercise: slight (0), moderate (1), and intense (2).
• Transformation of the level of studies in a classification of three levels with their assigned numerical
coding: basic/high school (0), medium/bachelor (1), and superior/university studies (2).
• Weight transformation in a three-tier classification: less than 60 Kg (0), between 60 and 85 Kg (1),
and greater than 85 Kg (2).
• Height transformation in a three-level classification: less than 158 cm (0), between 158 and 185 cm
(1), and greater than 185 cm (2).
• Transformation of the body mass index (BMI) into a three-tier classification: under 24 (0), between 24
and 30 (1), and over 30 (2).
• Grouping of the cervical pain periodicity to create a variable of three levels: sporadic (0),
discontinuous (1), and frequent (2).
The completeness and quality of the data recorded is also a key aspect in any ML pipeline,
and particularly in the health area. In our case study, some variables were initially incomplete, due to
the lack of collected data from certain patients (five patients). These incomplete data were related to
specific features (e.g., the workplace of the patient, his/her age, the dominant side of his/her body,
the date of the traffic accident, etc.), and were later collected by a telephone call.
The encoded database is presented as Supplementary Material File S2, where the variables are
obtained after the transformations that are carried out from the initial database are collected and the
anonymized variables are highlighted (see Variable_View).
3.4. Stage 4: Data Selection
The next stage is to filter the encoded database obtained in the previous phase and select
the most useful variables, applying different filters in a way that will lead to obtaining a filtered
database, which will be the basis of the predictive model. Possible successive filters to be used include
the following:
1. Filters due to ethical and legal issues: Discard personal or private variables and those that are
unimportant for the purpose of the predictive model, such as names, clinical history numbers,
telephone numbers, and addresses. The filtered database must be anonymous with respect to
existing regulations on the protection of personal data, so a previous anonymization process
becomes essential in order to keep as much important data as possible. Notice that during
the previous step (data transformation, see Section 3.3), some data are transformed to increase
privacy; in this step, privacy might need to be further increased by not selecting some sensitive
data in case those data have not been properly transformed previously or in the case of other
sensitive data that are irrelevant for predictions.
2. Manual selection: Screening based on the needs set by the target of the prediction, removing
outliers or variables with a lot of missing data [5]. It is highly recommended that this filtering be
conducted by an expert in the healthcare field.
3. Automated attribute selection: specific software and algorithms can be used for filtering,
calculating the gain ratio for each of the variables and rejecting those with low predictive
power—for example, using regression techniques.
Application to Our Case Study
In our case study, the encoded database initially included 230 variables in the initial dataset
(the “Coded database”), which were reduced to 28 after the following consecutive filtering steps
(see Table 2):
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1. The removal of variables related to personal and ethical data not anonymized previously and
with no predictive power. The variables name, surname, telephone number, address, and email
were removed in this filtering.
2. Manual filtering performed by physicians and technologists, corresponding to non-objective
or inappropriate variables in the medical legal/forensic field (e.g., the sensation of instability,
mobility limitation, pain periodicity, etc.), as well as variables with missing data that could not be
completed (e.g., the position of the head and type of effect in case of a traffic accident, intensity of
work, etc.). In this filtering, 74 variables were removed according to the criteria indicated.
3. Finally, a filtering was applied based on the gain ratio of the variables. We used the IBM SPSS
modeler software [62] (v. 18), discarding 123 variables with low predictive power (we selected
those with a gain ratio higher than 0.95 out of 1). Variables such as the average angle, standard
deviation, complementary angle, weight, height, etc., were selected. The selection of these
28 variables is consistent with the target variable (the presence or absence of pain) and its
associated requirements, since it is a desirable situation for clinicians that these variables are
objective, represent the main cervical movements, and correspond to clinical data objectively
acquired by the clinicians.
Table 2. Final variables considered in the case study after feature selection.
Patient









Mean Speed [◦/s] in: Flex.-Ext. Rotation Lateralization
Max Speed [◦/s] in:
Flexion Right Rotation Right Lateral
Extension Left Rotation Left Lateral
Max Angle [◦] in:
Flexion Right Rotation Right Lateral
Extension Left Rotation Left Lateral
Total Range [◦] in: Flex.-Ext. Rotation Lateralization
Total Length [◦] in: Flex.-Ext. Rotation Lateralization
Table 2 shows the 28 final variables of the filtered database; the detailed information of each variable,
with the different associated values for the different data instances, is included as Supplementary
Material File S3.
3.5. Stage 5: Predictive Model Generation and Evaluation
In the next stage, a predictive model according to the established objective is designed based
on the filtered database obtained in the previous stage. To do this, we must select those algorithms
that are considered viable for the specific clinical project, such as decision trees, neural networks,
or support vector machines (SVM), among others [63]. If the volume of data is very high, the use of
specific support software can facilitate selecting a suitable algorithm by performing iterations before
generating the full predictive model. For example, the IBM SPSS modeler classifier node (v. 18) can
create several models and then compare them to select the best approach for a particular analysis.
In this stage, the performance of the selected algorithms should be tested to choose the most
convenient one to implement in the predictive model. To evaluate their stability and effectiveness,
different cross-validation approaches can be considered [19,30,64–66]. The simplest method consists of
separating the sample into two sub-samples: one to train the model and another one to test it (holdout
method). Other more advanced methods include dividing the sample into k sub-samples (k-fold
cross validation), stratifying the sample with the same percentage of each class (stratified k-fold cross
validation), or even making as many combinations as the number of data instances (leave-one-out cross
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validation). Furthermore, a validation set could be used (besides the “test set” and the “training set”),
which is a set of examples used to tune the parameters of a classifier [67]. This is useful because the
performance of the selected algorithms can be improved through parameter tuning, which consists of
varying values of parameters of the algorithms in order to find the most suitable configuration for each
of them. Once the suitable parameter configuration for each algorithm is selected, the performance of
the different algorithms can be compared.
It must be stressed that the most appropriate prediction method depends on the data. Besides,
overfitting (a phenomenon that occurs when the adjustment of the model to the training data is too
strong and, as a consequence, finds difficulties in obtaining suitable conclusions about unobserved
data) should be avoided, as this would lead to a model that will only be able to make predictions
for the data with which it has been trained [52]. There are several techniques to deal with this,
such as regularization (smoothing the models), data augmentation (increasing the training data),
early stopping, etc. As an example, early stopping implies that the training process of the model must
be stopped before overfitting [30,68,69], that is, before the model adjusts too much to the training data
(i.e., before the performance of model gets worse on the validation data).
Over-parametrization is a recurrent problem in the application of ML techniques in healthcare,
where there are cases where the ratio between variables and data is very high and overfitting effects
can occur. The opposite can also happen when the volume of data is very high, but the number of
variables is excessively reduced and/or has little predictive power. Therefore, if needed, depending on
the results obtained we could come back to Stage 4 “Data Selection” to reduce the number of variables.
As a guideline, to avoid over-parametrization the 1 to 10 ratio between variables (attributes or features)
and data (number of instances) should not be exceeded [20,52]. If there was a smaller ratio between
the variables and data, a more exhaustive screening of variables would have to be carried or a larger
sample would have to be obtained. In terms of classification, having an excessive number of variables
will lead to not solving the problem or not achieving the proposed objective because the model will
only be able to classify the training data correctly [70].
To select the most suitable algorithm for the project, it is necessary to follow an organization
strategy, storing each previous version and modification of the project [52]. In this way, the results are
contrasted (training data, validation, errors, etc.). After the selection of the most effective algorithm,
we will be able to generate the definitive predictive model that incorporates the already-existing filtered
database. If the predictive model were evaluated positively, a continuous learning process could begin
by receiving periodic information from the assessment tests performed on future patients, as shown
in Figure 3.
Application to Our Case Study
In view of the target of our clinical study to classify the presence of cervical pain, only supervised
learning algorithms must be selected, dismissing unsupervised learning algorithms. The algorithms
selected in our study were logistic regression [71], decision trees [72], random forests [73], SVM [73],
neural networks (MLP neural networks) [74], k-Nearest Neighbors (KNN) [73], and Gradient Boosting
Algorithm (GBA) [75]. All these are popular supervised machine learning approaches. The main
parameters selected to perform the parameter tuning of those algorithms are shown in Table 3. In our
experimental evaluation, we combined the parameters of each algorithm presented in Table 3 using the
software tool Weka [76] (v. 3.8); specifically, for the parameter tuning we used the Weka Experimenter
user interface.
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Table 3. ML approaches considered and their main parameters.
Approach Main Parameters
Logistic regression Ridge value in the log-likelihood: from 10
−4 to 10−12 (parameter
change every 10−2).
Decision tree (C4 pruned) Number of instances per leaf: 3/5/10/15/20. Confidence factor forpruning (Conf.): 0.15/0.25/0.35.
Random forest Maximum depth of the tree: 3/4/5. Number of trees: 25/50/100/200.
Support vector machine (SVM)
Tolerance: 10−3. Kernel function: radial basis function (RBF).
Epsilon for round-off error:
10−12. Complexity (C): 0.25/0.5/1/2/4. Gamma (kernel width):
0.01/0.25/0.5/1/2.
Neural Network (MLP neural network)
Type: multilayer perceptron (MLP). Learning Rate (LR, the amount
the weights are updated): 0.2/0.3/0.4/0.5. Momentum (Mom.,
applied to the weights during updating): 0.1/0.2/0.3. Number of
epochs for training: 500. Number of hidden layers: 15. Auto-built
option in Weka set to true.
K-Nearest Neighbors (KNN) Number of Neighbors (K): 1/3/5/7/9/11/13/15/20. Distance function:Euclidean distance, Manhattan distance.
Gradient Boosting Algorithm (GBA) Iterations (Iter.): 10/20/50/100. Weight threshold (W.T.): 50/100/200.AdaBoost implementation provided by Weka.
In our case study, the predictive models generated by applying the previously selected algorithms
are shown in Table 3. As mentioned previously, the DM software used in this study was Weka (v. 3.8).
Considering the current availability of data for our case study, the performance of each parameter
configuration of each algorithm was tested using a validation set which is the same as the test set;
using the same set for validation and testing is not the ideal situation, but we decided not to reserve a
part of the available dataset for validation because of the moderate size of our sample. We considered
the accuracy metric (i.e., the percentage of instances correctly classified) for determining the most
suitable algorithm configuration. Figure 5 shows the performance of the algorithms obtained during
parameter tuning using a k-fold cross validation (k = 10).
Consequently, the parameter configuration selected for each algorithm is shown in the first row of
Table 4. The effectiveness of the models generated by k-fold cross validation (k = 10) was evaluated.
The following metrics were computed in order to determine the most suitable algorithms (see Table 4):
the accuracy (the percentage of instances correctly classified), the precision (the percentage of patients
with pain correctly classified over all the patients labelled by the algorithms as patients with pain),
the recall/sensitivity (the percentage of patients with pain correctly classified over all the patients with
real pain), the specificity (the percentage of healthy patients correctly classified over all the patients
who are really healthy), and the F1-score (the harmonic average of the precision and recall).
We have noticed using the software Weka, which provides the attribute weights of each model in
the results display section, that the variables with greater predictive power in all the predictive models
evaluated are the following: maximum speed in all the movements, the existence of a traffic accident,
and the presence of a contracture. In our case study, there is no indication of over-parametrization;
as described in Section 3.4, we have a sample of 302 instances and 28 selected variables, which complies
with the 1 to 10 ratio between the variables and data.
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Accuracy 86.6% 95.4% 83.7% 87.7% 91.8% 83.4% 87.1%
Precision 88.6% 95.4% 86.9% 86.1% 93% 83.5% 87.1%
Recall/Sensitivity 89.6% 97.8% 84.1% 92.3% 92.5% 91.2% 92.9%
Specificity 82.5% 91.7% 80.8% 76.6% 90.5% 71.7% 78.3%
F1 Score 89.1% 95.3% 85.5% 88.9% 92.8% 83.2% 86.9%
3.6. Stage 6: Interpretation of Results and Model Selection
Once a statistically acceptable predictive model has been created, it can be deployed to be used in
production, since it can provide predictions with good accuracy to support decision-making (Figure 4,
stage 6). However, for the exploitation of the model, it is necessary first to evaluate the degree of
correlation between the results obtained and the previously defined clinical target (in our case study,
the prediction of cervical pain). Besides, some models (e.g., the tree-based classifiers) could be explored
to analyze which particular features are the most decisive factors in the classification model.
If the evaluation of the correlation does not yield satisfactory results—that is, if the consonance
of the results with the target is not achieved or the model does not have enough predictive power
according to the minimum goals established initially—the previous stages must be repeated with the
objective of improving and optimizing the process according to the target initially set, leading to an
iterative process (see Figure 4) [20,77]. There can be several causes of low correlation or poor predictive
power:
• The target is difficult to achieve or too complex;
• Patients are inadequately characterized;
• The sample is insufficient;
• The data include variables that are not necessary (e.g., irrelevant variables, confounding factors,
or redundant variables) or do not include those that are;
• Problems exist in the predictive model generation stage regarding the selected algorithm [78],
overfitting, or over-parameterization.
For effective deployment, not only the accuracy of the models but also the resources must be
considered. For example, the scalability requirements are key when you have high volumes of data
to avoid very long training times, lack of memory, etc. This is important in terms of productivity,
portability, cost reduction, the minimization of staff involvement, etc. In cases where large volumes of
data have been collected for many years (cancer studies, studies of discharge from the hospital and
sick leaves, etc.), scalability acquires a transcendental role [30].
Application to Our Case Study
Based on the results collected in Table 4, a quite good performance of all the algorithms can be
observed for most metrics. Considering the large number of variables available initially, the rigor with
which all the data were obtained by the multidisciplinary team, and the adequate selection of variables
carried out in previous phases (choosing the objective variables and with a greater predictive power),
a suitable prediction performance was initially expected.
Considering the minimal target values of the statistical measures established in Stage 1 “Clinical
target definition”, several algorithms fulfil the requirements in terms of the target metrics:
• Accuracy (>85%): logistic regression, SVM, random forest, MLP neural network, and GBA.
• Precision (>85%): logistic regression, SVM, decision tree random forest, MLP neural network,
and GBA.
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• Recall (>90%): SVM, random forest, MLP neural network, kNN, and GBA.
According to the results, the four algorithms that fulfil the requirements are SVM, random forest,
the MLP neural network, and GBA. From all these algorithms, SVM achieves the best results in all the
metrics considered, and therefore it could be the model selected for production.
3.7. Stage 7: Operating Profit and Clinical Use
The last stage (Figure 4, stage 7) concerns the adaptation and organization of the acquired
knowledge and the predictive capacity of the system to make it accessible to the physician [47].
At this point, it is important to emphasize the key role played by the expert medical professionals
(final decision makers) in interpreting the results, in determining whether certain patterns observed
make medical sense and are relevant, or in clearly distinguishing between correlation and causality
(as studied for different heath topics [79,80]). The “intelligence” provided is not intended to replace
the physician but to advise and guide his/her decisions, which will always prevail [20].
Application to Our Case Study
The results obtained directly by the model may involve difficulties when interpreted by the
physicians. That is why the information presented to them must be intuitive, simple, and easily
interpretable. In this regard, a concise graphic and clear report, where the results of the test and the
prediction of the pathology/target variable to be predicted are presented, can help the clinical to more
easily interpret the test performed and the results of the predictive model. This paper is accompanied
by a report example as Supplementary Material File S4, showing a possible example of a report for our
case study that includes patient data, test results in a tabular and graphic format, and an area showing
the prediction of cervical pain obtained by the model.
Once the model enters production, it will be possible to add data regarding new patients both
with or without cervical pain and verified diagnosis, which would increase the sample and thus the
predictive power.
4. Discussion and Lessons Learnt
In this paper, the particularities of applying ML techniques in the field of healthcare are shown,
developing all the stages that comprise it, to generate reliable and stable models. It has been exemplified
through a case study of cervical pain evaluation, where we have been able to predict the presence
of cervical pain with accuracy, precision, and recall above 85% with the approaches based on SVM,
random forest, MLP neural networks, and GBA.
In order to clarify and structure the knowledge acquired during the development of the current
study, a summary of some key aspects and lessons learnt regarding DM and ML in the field of healthcare
is shown in Table 5. Every key aspect has been categorized in a general classification, followed by a
description, the real situation exemplified in our case study, and some important related references.
Table 5. Summary of the key aspects and lessons learnt.




according to the aims and
clinical needs.
This facilitates the subsequent
selection of data.
Presence of cervical pain.
Only collaborating subjects





Minimum metrics to be fulfilled
by the model according to the
clinical target. Metrics are
checked in stage 6
(interpretation of results) after
the predictive model generation.
Performance required:
accuracy: greater than 85%;
precision: greater than 85%;
recall: greater than 90%.
[39]
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Diversity of the origins of data
in healthcare (regarding
typology, consistency, and
veracity) and need to correctly
understand the data.
A health expert is required in
this stage.
Prior to the field work,
relevant clinical information
was identified and the tests




Categorization of data using
appropriate variables/features,
applying classifications
motivated by medical needs.
This is essential to carry out an
adequate analysis of the
information.
Data classification motivated











Reducing the raw data to be
handled and adapting them to
the required format in order to
increase the predictive power.
Variables such as the age,





with a numeric code.
[5,19,47,52]
Anonymization
Preservation of sensitive patient
data by transforming values of
data variables into scales or
groups, thus avoiding patient
identification.






discrete variables and the
removal of identifying




After data transformation, the
selection of variables applying a
filter according to the
target:ethical and legal issues,
manual selection, automated
attribute selection.
The volume of data in the
case study was reduced








where variables that can take







Completeness and quality of the
data recorded as a key aspect in
the health area.
Incomplete data from 5
patients related to specific
features were collected
through a telephone call.
[81]
Over-parametrisation
Need not to exceed the 1 to 10
ratio between variables and data
to avoid overfitting. The
dimensionality is an issue in
studies with a high number of
variables compared to the total
number of samples.
This was a real issue in our
case study because of the
volume of data provided by
sensors.
A sample of 302 and 28
variables was finally
selected, which complies
with the 1 to 10 ratio.
[20]
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Table 5. Cont.
Category Key Aspect Description Case Study SampleReferences
Scalability
Support for handling large
amounts of data (efficient and
effective collection, storage,
management, and exploitation).
Depending on the project
duration, and especially if it is
intended to have an adaptive
character (projects with data
collected for many years),
scalability is a key issue to
consider.
The current project is still in










Minimization of the number of
false negatives (increasing
recall). This is a key goal in
healthcare, since false negatives
and false positives have no
similar costs in this area. The
precision should also be suitable,
as a high number of false
positives would lead to false
alarms, the performance of
needless procedures, and
increasing costs and discomfort
for the patients.
The selected algorithms
(SVM, random forest, MLP






work as a key point
Composing teams involving
technical people and diverse
health professionals. This is
required, but not always
possible. Insufficient
collaboration could be
diminished by applying the
stages assigned to each of the













Improvement of the model
performance thanks to a
continuous learning process.
There is an intention to
improve the current system






We expect the applicability
of the proposal in the
forensic field as an objective
system of application to aid
in judicial processes.
[19,82]
Data structuring. A clear and concise structuring of the data is essential to carry out an adequate
analysis of the information as well as to make this information really useful for the purposes of the
predictive model. In our case study, and prior to the field work, the relevant clinical information
was identified and the tests to perform were determined (cervical ROM in three different planes with
a MoCap system of inertial sensors), so that its processing and subsequent structuring were easier.
It is essential to accurately structure the available information in a suitable way (using appropriate
variables/features) when working with large volumes of data, and to classify the different variables
in different groups (using appropriate categories) to facilitate access (for all the parties involved) in
a more effective and useful way. Data management is so important that the preparation of the data
covers three of the seven stages of the methodology (stages 2, 3, and 4).
Selection of variables. Likewise, the selection of the most adequate information to predict a
certain characteristic, as well as its transformation in terms of variables, is essential. In relation to this
adaptation, sensitive patient data must be anonymized for their use in the generation of a predictive
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model [19,21]. Although converting continuous predictors to discrete variables (specifically binary
variables) is not always recommended [20], the necessary transformation of data for privacy reasons in
the field of health conditions the stage of data transformation. The reduction in the volume of data
in the case study was from 230 variables to 28 due to the large number of variables provided by the
inertial sensors and the clinical data. The variable reduction applied (based on the gain ratio of the
variables) after the corresponding selection of the data for ethical and legal issues and the screening
made by an expert was necessary to fulfil the 1 to 10 ratio between the variables and data. This key
point allowed us to ensure that the predictive models work properly, maximizing the predictive power
and avoiding overfitting.
Selection of the predictive model. Regarding the selection of the predictive model, after performing
a parameter tuning of the seven selected algorithms and comparing the most suitable configuration of
each of them (see Figure 5), it was concluded that the models that meet the established requirements
regarding accuracy, precision, and recall for the case study were SVM, random forest, MLP neural
networks, and GBA. Our results highlight the low number of false negatives achieved (high recall),
a fundamental aspect in healthcare studies [39]. These results are in agreement with other investigations
of a similar nature, using the same software (Weka), in terms of the accuracy, precision, recall, and F1
score with the SVM and random forest algorithms [36].
Variability of the measures acquired. It has been detected that it is possible to assess the measurement
capacity of our medical equipment in terms of the variability of the measures that it obtains. A series
variable identifies whether the data are relative to the first measure of each subject or to the second
(which was performed consecutively). The results obtained by the predictive models showed that there
were no differences between the two series of cervical ROM (this variable had the lowest predictive
power among all the variables introduced in the model). This result indicates that the measure has
behaved stably in collaborating subjects. This result is interesting in the forensic field due to the
following reason. If repeating the cervical ROM test in a patient results in significant differences,
they would not be derived from the variability of the test, but by the type of pathology that prevents
the patient from repeating the test normally. Alternatively, the patient may try to simulate or magnify
the lesion by not showing consistent results between the first and second series. This aspect would be
of relevance to judicial experts [29,83].
Data collection in production. Once the system is applied in its context and has been developed,
continuous data collection must be planned in production in order to improve the prediction accuracy,
resulting in a continuous learning system (Figure 3). In the case study, to increase the sample in the
exploitation stage of the model it is possible to include those patients who perform cervical assessment
tests in a care or rehabilitation setting; thus, their sincerity can be assumed regarding the degree of
cervical pain as well as full collaboration in the performance of the tests. However, for the collection
of training data it may be necessary to exclude those patients who are immersed in a judicial and
indemnifying process and who report cervical pain because their degree of collaboration or sincerity
is unknown. In the future, the system can be used to predict the cervical pain of non-collaborating
patients (e.g., patients in a judicial process or patients with a high degree of anxiety or hypochondriacs)
from the predictive model previously generated with collaborating patients, serving as objective
evidence in judicial proceedings with insurance companies [40].
Multidisciplinarity. For a correct interpretation of the results, multidisciplinary work is a key
point, since the contribution of each of the branches of knowledge is necessary in this type of project
to optimize the possibilities offered by the model. In this way, it will be possible to assess the
statistical quality of the results and their medical utility. For example, in our case study questions were
raised regarding the way the data and the results should be represented (solved with the databases
defined and the design of a report for physicians, presented as Supplementary Material), the possible
interpretation and use of the system by the clinician (problems could have arisen if we had not been
worked in close collaboration with the clinicians; however, the target variable and how to present
the results were clarified from the beginning of the project), and the overlap with other possible
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decision-support systems (if other systems could also provide in the future a prediction indicating that
a patient suffers cervical pain, both results would be presented to the clinician and he/she would take
the final decision). Through collaboration with the medical experts, these issues have been solved.
However, multidisciplinary work is not always possible, since professionals participate in different
stages of the entire process according to their degree of knowledge, experience, and training, so in some
cases there may be no direct or sufficient interaction between them [34]. This lack of interaction among
professionals could be diminished by following the stages assigned to each of the professionals in a
concise and structured way, thus avoiding problems that may lead to project failure [52]. In the case
study, the rigor followed by the different professionals involved in the different stages have resulted
in adequate results. Nevertheless, although there has been interaction between them, it could have
been done in a more collaborative way, since clinical experts were not present in the generation of the
predictive model and the interpretation of the results, which could have improved the quality of the
study thanks to its specific medical knowledge.
Exploitation of sensor data. The use of sensors and devices with the use of ML could be implemented
as a complementary objective test to help physicians. This type of test could constitute an aid to the
decision-making in the diagnosis or treatment, or if there is doubt about the veracity of the information
reported by the patient [19,82]. Although we wanted to show the clinical utility of this type of
technology, the lack of studies on the application of ML techniques with motion capture sensors in
healthcare, and specifically their applicability in the forensic field as an objective system of application
in judicial processes, have further motivated the choice of the case study. Therefore, while our case
study focuses on the medical legal/forensic field, the procedure proposed to use ML techniques could
be applied in any study of the health field (cancer detection, studies of discharge from the hospital and
sick leave, etc.).
Use of resources. Regarding the frequency and regularity of data acquisition, it is necessary to
previously estimate it to limit the duration of the project [34], as well as to quantify the necessary
storage size, which is a factor with high variability between projects. If the project is intended to have
an adaptive character that can be applied or expanded for subsequent research, the scalability and
magnitude should be considered. If the scalability of the project is not considered, and the intention is
to continue acquiring data and adapting the model to the continuous growth of information, there may
come a time when the project is no longer viable because it is unable to assimilate the corresponding
increase in data size. This situation is common in epidemiological projects of data collection for large
periods of time, where the scalability is transcendental for the future of the project [30]. On the other
hand, it is important to consider that, in certain projects as in the case study presented in this paper,
the ratio between available variables and data can be high. So, not exceeding the 1 to 10 ratio between
variables and data is transcendental to avoid overfitting effects [20].
5. Conclusions and Future Work
Through a practical guide, the stages and particularities to consider for the application of ML
techniques in the field of healthcare have been described, considering all the stages involved in the
process. This procedure is shown through objective cervical functional assessment tests that use
MoCap technology with inertial sensors and a predictive model whose goal is to estimate the presence
of cervical pain from the data collected with the test. Four models (SVM, random forest, MLP neural
network, and GBA) from the seven models initially generated obtained an accuracy and precision of
more than 85% and a recall of more than 90% (i.e., the percentage of false negatives is smaller than
10%). The approach and the results obtained could help objectify diagnoses, improve test treatment
efficacy, and save resources in healthcare systems. The procedure, which has been applied to data
derived from a cervical assessment study for verification and evaluation, is also appropriate for any
healthcare field regardless of the origin of the data. It can be useful, for example, in gait studies [82],
balance studies [84], cardiac failure studies [85], the prediction of events [86], fertility tests [87], etc.
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Despite the great usefulness of ML in the field of healthcare, some limitations have been detected
in this field. First, a major limitation is how to achieve a suitable flow of data from health centers and
hospitals, as well as the accessibility (in relation to privacy policies and authorizations) [21], gathering,
and integration of the data [3]. If a global information collaboration policy were established between
hospitals [6,69,88], the problem of access to information could be solved, and it would be possible
to share more data and feed the predictive models applied to the field of healthcare more efficiently.
The explainability of predictions [89,90] is an important issue in a health care domain, as it could
increase the trust in the ML systems (for both clinicians and patients) and even lead to the acquisition
of new knowledge; however, more research on how to achieve explainability while considering the
potential trade-off with accuracy must be performed, especially in the health domain.
Regarding the limitations of the conclusions obtained with this case study, once the model is in
the exploitation stage it would be advisable to carry out an external validation to verify the viability of
the model in terms of geography, temporality, etc. [30,77]. Regarding the data sample used in our case
study, its size has been large enough to obtain good results, but it would be relevant to see the impact
of increasing it, as new data about patients becomes available, to enable a continuous learning process
that could lead to better results over time. Besides, a study is currently being conducted to check the
accuracy of the proposed models with a sample of non-collaborating patients.
Concerning the target variable (presence of cervical pain), which is a binary variable, it could
be defined in a more granular way considering not only the presence of pain but also its intensity
(as a continuous variable or as a discrete variable with several pain degrees). The problem with pain
intensity is that pain scales are highly dependent on the subjectivity of the patient, and this issue could
be further exacerbated with non-collaborating subjects. However, as a future goal of our research,
it could be useful to tackle this issue and introduce some statistical techniques, such as the numerical
measurement z-score, to normalize the subjective values from pain intensity scales (e.g., the Visual
Analogue Scale) provided by the patients. The z-score could help to reduce the bias of patients,
allowing us to include pain intensity as a target variable in our proposal.
Finally, as future work, it could also be interesting to extend the range of experiments performed
and analyze the potential interest of other ML methods; for example, we could consider applying
different classifiers applied over different categories of data proposed in the paper and combine them
into an ensemble.
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